Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency

Top Posts

LAU Medical Center–Rizk Hospital Mobile Clinic in a...

MOU Signing Between the University of Balamand and...

Beirut’s largest park transformed into a symbol of...

OMEGA Ambassador Rory McIlroy Triumphs at Irish Open

Unlock the Secrets of Prague with the New...

Emirates Skywards introduces flight rewards in Premium Economy

OMEGA Welcomes Eddie Redmayne to a Swiss Golfing...

Thriston Lawrence wins The OMEGA Masters 2025

Salam: “Education First, Children First. We Will Not...

Lilly’s Verzenio® (abemaciclib) increases overall survival in HR+,...

Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency

Home Tags Posts tagged with "Empagliflozin"

Tag:

Empagliflozin

Lifestyle & Health slider
Landmark trial, EMPEROR-Preserved, demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction

by Karine Ayoub November 2, 2021

by Karine Ayoub November 2, 2021

In this clinical study for adults with heart failure with preserved ejection fraction, empagliflozin…

0 Facebook Twitter Pinterest Email

Weekly Notification

Bulletin’s Archive

Bulletin’s Archive

Search Bulletins

Tags

Abu Dhabi Ports American University of Beirut American University of Sharjah (AUS) AUB aubmc Bank Audi Blom Bank Breitling Byblos Bank cannes lions Corona Virus (COVID-19) COVID-19 Corona Elie Saab Emirates Ericsson Garena Free Fire Gartner Global Village Globemed Grohe Huawei Hyundai Kandima Maldives Kia Kia Corporation LAU Medical Center Rizk Hospital LG LG Electronics Maserati Mastercard NISSAN PRCA MENA Ralph & Russo Ramadan Rebirth Beirut Salesforce Samsung SAP Starzplay Tony Ward UN UNICEF United Nations VFS Global Zuhair Murad

THE BULLETIN

All press releases and company news, brochures, logos, videos, images, and brands are property of their respective owners and not the bulletin.
All press releases and company news, brochures, logos, videos, images, and brands references used in this website are for identification and informational purposes only.
Use of these press releases and company news, brochures, logos, videos, images, and brands does not imply endorsement by, sponsorship by, or affiliation with the bulletin.

JOIN US

About us
Contact us
HOME

Keep in touch

Facebook

@2024 - All Right Reserved.